China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

China flag China · Delayed Price · Currency is CNY
18.20
+0.26 (1.45%)
At close: Mar 6, 2026
-4.01%
Market Cap 18.79B
Revenue (ttm) 10.95B
Net Income (ttm) 1.58B
Shares Out 1.03B
EPS (ttm) 1.53
PE Ratio 11.89
Forward PE 10.68
Dividend 0.47 (2.59%)
Ex-Dividend Date Oct 28, 2025
Volume 6,324,427
Average Volume 6,912,717
Open 17.94
Previous Close 17.94
Day's Range 17.86 - 18.26
52-Week Range 17.34 - 22.14
Beta 0.06
RSI 42.45
Earnings Date Mar 20, 2026

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing... [Read more]

Sector Healthcare
Founded 1939
Employees 13,414
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600062
Full Company Profile

Financial Performance

In 2024, SHA:600062's revenue was 11.21 billion, a decrease of -0.87% compared to the previous year's 11.31 billion. Earnings were 1.63 billion, a decrease of -2.55%.

Financial Statements

News

There is no news available yet.